Trial NCT00594230

View at ClinicalTrials.gov 
Org. Study IDs: SCRI MDS 07

Last trial update was posted on 2021-11-22

MeSH Interventions

Panobinostat

MeSH Conditions

Myelodysplastic Syndromes Preleukemia Syndrome

Other Conditions

Myelodysplastic Syndromes (MDS)

Stopping Reasons

Per protocol, the results of a planned interim analysis demonstrated insufficient efficacy and led to early termination of the study.

Limitations And Caveats

Results of a planned interim analysis demonstrated that the regimen did not demonstrate sufficient evidence of efficacy necessary to justify further enrollment. Per protocol, the results of this analysis led to early termination of the study.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID